IFN-γ can inhibit the proliferation of lung adenocarcinoma cells by activating the JAK2-STAT1 pathway, and blocking the PI3K-AKT pathway can enhance the anti-proliferation ability of IFN-γ (Gao et al., 2018). Here, JAK2 is linked to lung adenocarcinoma.